UR-144

UR-144 is a synthetic cannabinoid that is used in laboratory research. It was first synthesized by the pharmaceutical company Abbott Laboratories, but it was never marketed by the company. UR-144 has been detected in products sold as synthetic cannabis and it is completely banned in some countries due to its potential for abuse.

Chemistry

UR-144 is a type of synthetic cannabinoid, which are a large family of chemically unique substances that mimic the effects of cannabis. The chemical structure of UR-144 is different from other synthetic cannabinoids, which means it may have different effects and risks. UR-144 is closely related to compounds like JWH-018 and AM-2201.

Effects

The effects of UR-144 are not well studied. However, it is known to act as a full agonist at the CB2 receptor and a partial agonist at the CB1 receptor. This means it can produce a range of effects such as euphoria, relaxation, and changes in perception. However, it can also cause negative effects such as anxiety, paranoia, and psychosis in some users.

Legal status

UR-144 is illegal in many countries, including the United States, United Kingdom, New Zealand, and Sweden. It is also banned in some states in the United States. The Drug Enforcement Administration (DEA) has classified UR-144 as a Schedule I controlled substance, which means it has a high potential for abuse and no accepted medical use.

See also

• Synthetic cannabinoids
• Cannabinoid receptor
• Abbott Laboratories

UR-144 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia

References

External links

• UR-144 Drug Fact Sheet from the Drug Enforcement Administration
• UR-144 Critical Review Report from the World Health Organization